Research and Development

Swiss-based Roche has forged a partnership that could lead to the development of new treatments for schizophrenia, cognitive disorders, Parkinson's …

GlaxoSmithKline has bought US-based biotech company, Praecis, to further boost its novel cancer pipeline.Its acquisition of Praecis Pharmaceuticals follows the …

Swiss-based biotech company Speedel has axed its current phase III trial of SPP301 in diabetic kidney disease because of patient …

News that a new strain of the MRSA bug has reached Europe from the US has left drug developers under …

Novartis, in collaboration with a US biotech company, has initiated phase III trials of a chronic hepatitis C drug that …

UK-based biotech company Protherics has raised £38 million, which will be split in a three-pronged move to expand its development …

GlaxoSmithKline Biological's mock pandemic flu vaccine has received a positive opinion from EU regulators.Daronix is intended to protect against flu …

The UK's National Cancer Research Network has given its backing to a phase IIb trial of a promising vaccine for …

GlaxoSmithKline has bought Cambridge-based antibody firm Domantis for £230 million.Domantis, a leader in developing the next generation of antibody therapies, …

Oxford BioMedica's leading cancer immunotherapy vaccine has received a positive opinion as an orphan drug for renal cancer from the …

Wide-ranging changes will be made to the way clinical trials are conducted in the UK following the final report by …

Faster approval of NHS clinical trials and NICE recommendations are almost certain following a fundamental shake-up in the way UK …

Novartis will launch Prexige in its first European markets outside the UK next year following its EMEA approval for osteoarthritic …

One of the key drivers of much of the recent merger and acquisition activity within the pharmaceutical industry is the …

Pfizer has suffered a major blow with its decision to cancel late-stage pipeline torcetrapib following safety concerns.Torcetrapib, which raises 'good' …